GoldenGolden
Advanced Search
DeNovo Ventures

DeNovo Ventures

DeNovo Ventures is a Saratoga, California-based company founded in 2000.

DeNovo Ventures is a venture capital firm based in Saratoga, California and founded in 2000.

With $650 million under management, DeNovo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth - from early stage to late stage. They work to advise entrepreneurs and management teams over the full life cycle of their portfolio company.

Investment

DeNovo Ventures has made investments in Avedro, TearScience, Benvenue Medical, Spinal Kinetics, EndoGastric Solutions, MyoScience, TRIA Beauty, Avedro, Astute Medical and WaveTec Vision.

They exited their investments in Avedro, MyoScience, Astute Medical, AxoGen, OncoMed Pharmaceuticals, TearScience, Spinal Kinetics, Spinal Modulation, WaveTec Vision and Renovis.

Funds

DeNovo Ventures has raised a total of $650 million across three funds. They announced their De Novo Ventures I on January 2000, with a raised total of $100 million. In January 2004, they announced their De Novo Ventures II with a raised total of $250 million. And in January 2006, the announced their De Novo Ventures III with a raised total of $300 million.

Timeline

People

Name
Role
LinkedIn

Colleen Cody

Employee

Frederick Dotzler

Managing Director

Henry Mire

Employee

Joe Mandato

Managing Director

Richard M. Ferrari

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
April 22, 2021
BioSpace
BIOMODEX®, a pioneering digital health company that offers advanced 3D printed solutions for patient-specific rehearsal and physician training, today announced the appointment of Rich Ferrari to its Board of Directors.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.